Related Experiment Video

Updated: Jun 30, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

[Any way you splice it: Mdm2 at the crossroads of tumor surveillance]

Nathan H Lents1

  • 1Department of Sciences, John Jay College of Criminal Justice, The City University of New York; New York, New York, USA. nlents@jjay.cuny.edu

AI Zheng = Aizheng = Chinese Journal of Cancer
|September 19, 2008
PubMed

Insights

A novel Mdm2 splice variant, Mdm2(+108), is induced by specific chemotherapy drugs. This variant truncates Mdm2 protein, leading to p53 accumulation and engaging tumor surveillance pathways.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Mdm2 is a key regulator of p53, a crucial protein in cellular stress response.
  • Alternative splicing of Mdm2 can produce aberrant protein products with unknown functions.
  • Understanding Mdm2 variants is vital for cancer therapy and understanding cellular stress pathways.

Purpose of the Study:

  • To investigate a newly discovered Mdm2 splice variant, Mdm2(+108).
  • To determine the functional consequences of Mdm2(+108) on p53 regulation.
  • To explore the role of Mdm2(+108) in response to chemotherapeutic agents.

Main Methods:

  • Analysis of Mdm2 mRNA splicing.
  • Identification and characterization of the Mdm2(+108) splice variant.
  • Assessment of p53 protein levels following Mdm2(+108) induction.
  • Treatment of cells with Adriamycin, Actinomycin D, and other DNA damaging agents.

Main Results:

  • A novel Mdm2 splice form, Mdm2(+108), was identified, incorporating intronic sequence and leading to truncated Mdm2.
  • Mdm2(+108) is acutely induced by Adriamycin and Actinomycin D, but not other DNA damaging agents.
  • Induction of Mdm2(+108) results in rapid and robust p53 accumulation.

Conclusions:

  • The Mdm2(+108) splice variant functions to engage the p53 tumor surveillance pathway.
  • This alternative splicing event restrains proliferation in cells damaged by specific genotoxic compounds.
  • Mdm2(+108) represents a targeted response to certain chemotherapeutic agents, highlighting a novel regulatory mechanism.

More Related Videos

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...